代谢物
化学
新陈代谢
葡萄糖醛酸化
类黄酮
体内
药理学
根皮苷
药代动力学
代谢组
药物代谢
硫酸化
韧皮部
生物化学
代谢途径
葡萄糖醛酸盐
生物利用度
色谱法
代谢组学
体外
苷元
葡萄糖醛酸
甘草苷元
初级代谢物
液相色谱-质谱法
生物转化
药效学
口服
活性代谢物
药品
芒果苷
谷胱甘肽
生物活性
辛尼格林
作者
Yuqing Zhao,Yali Yuan,Shu Yan,Chongzhuang Tang,Yong Gan,Shiyan Guo,Xingxing Diao
摘要
The total flavonoid extract of Lithocarpus litseifolius (Hance) Chun (TFLLC), a medicinal and edible plant of the Fagaceae family, has been developed as a preclinical drug candidate in China due to its hypoglycemic effect. The metabolism of TFLLC is closely associated with both its pharmacological activity and potential toxicity. This study investigated the in vitro and in vivo metabolism of TFLLC, which mainly comprises phlorizin and trilobatin. Ultrahigh-performance liquid chromatography coupled with UV spectrometry and high-resolution mass spectrometry (UHPLC-UV-HRMS) was used to detect and characterize TFLLC metabolites in rats following oral administration at 50 mg/kg. TFLLC underwent extensive metabolic transformation, and 13 metabolites were identified. The major drug-related substances included phloretin-derived from glycosidic cleavage of phlorizin and trilobatin-and its conjugated derivatives, such as glucuronidated metabolite M450, sulfated metabolite M354, and dual-conjugated metabolite M530. These metabolites were primarily excreted in bile and urine. Intestinal incubation studies confirmed that phloretin formation could occur in the gut. These findings provide a pharmacokinetic basis to support the pharmacodynamic interpretation and future drug development of TFLLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI